On Monday, Spruce Biosciences Inc (NASDAQ: SPRB) was 2.11% up from the session before settling in for the closing price of $0.12. A 52-week range for SPRB has been $0.11 – $0.87.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -10.26% over the last five years. When this article was written, the company’s average yearly earnings per share was at 46.90%. With a float of $29.20 million, this company’s outstanding shares have now reached $42.23 million.
The firm has a total of 21 workers. Let’s measure their productivity. In terms of profitability, gross margin is -14.36%, operating margin of -608.94%, and the pretax margin is -555.23%.
Spruce Biosciences Inc (SPRB) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Spruce Biosciences Inc stocks. The insider ownership of Spruce Biosciences Inc is 30.86%, while institutional ownership is 23.02%.
Spruce Biosciences Inc (SPRB) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 46.90% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.61% during the next five years compared to -16.93% drop over the previous five years of trading.
Spruce Biosciences Inc (NASDAQ: SPRB) Trading Performance Indicators
You can see what Spruce Biosciences Inc (SPRB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.29, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.67 in one year’s time.
Technical Analysis of Spruce Biosciences Inc (SPRB)
Analysing the last 5-days average volume posted by the [Spruce Biosciences Inc, SPRB], we can find that recorded value of 8.35 million was better than the volume posted last year of 0.92 million. As of the previous 9 days, the stock’s Stochastic %D was 4.63%. Additionally, its Average True Range was 0.04.
During the past 100 days, Spruce Biosciences Inc’s (SPRB) raw stochastic average was set at 2.41%, which indicates a significant decrease from 5.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 360.71% in the past 14 days, which was higher than the 151.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3295, while its 200-day Moving Average is $0.4357. Now, the first resistance to watch is $0.1317. This is followed by the second major resistance level at $0.1422. The third major resistance level sits at $0.1505. If the price goes on to break the first support level at $0.1129, it is likely to go to the next support level at $0.1046. Should the price break the second support level, the third support level stands at $0.0941.
Spruce Biosciences Inc (NASDAQ: SPRB) Key Stats
There are 42,231K outstanding shares of the company, which has a market capitalization of 5.12 million. As of now, sales total 4,910 K while income totals -53,040 K. Its latest quarter income was 700 K while its last quarter net income were -23,560 K.
